Cholesterol, VLDL - Blood
Research News and Information

Sunday, November 22, 2009

Decreased serum lipids in patients with probable Alzheimer's disease.

30 Jul 2009 Alzheimer;s disease (AD) is a multifactorial disease but its aetiology and pathophisiology are still not fully understood. Epidemiologic studies examining the association between lipids and dementia have reported conflicting results. High total ... Read more...

Control of ACAT2 liver expression by HNF4{alpha}: lesson from MODY1 patients.

26 May 2009 OBJECTIVE: ACAT2 is thought to be responsible for cholesteryl ester production in chylomicron and VLDL assembly. Recently, we identified HNF1alpha as an important regulator of the human ACAT2 promoter. Thus, we hypothesized that MODY3 (HNF1alpha ... Read more...

Changes in serum homocysteine level follow two different trends in patients during early post myocardial infarction period.

29 Apr 2009 The evolution of homocysteine (Hcy) changes after acute myocardial infarction is still not elucidated. Serum Hcy concentration has been shown to increase between acute and convalescent period after myocardial infarction and stroke. Also a decrease ... Read more...

Latest indexed articles for 'Cholesterol, VLDL - Blood'

These are the very latest articles for this heading:

• Decreased serum lipids in patients with probable Alzheimer's disease. 30 Jul 2009
• Control of ACAT2 liver expression by HNF4{alpha}: lesson from MODY1 patients. 26 May 2009
• Changes in serum homocysteine level follow two different trends in patients during early post myocardial infarction period. 29 Apr 2009
• A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. 27 Apr 2009
• Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats. 6 Apr 2009
• Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity. 30 Mar 2009
• Serum lipid concentrations in dogs with tail chasing. 27 Feb 2009
• Do serum lipids predict response to clozapine treatment? 27 Feb 2009
• Fasted to fed trafficking of Fatty acids in human adipose tissue reveals a novel regulatory step for enhanced fat storage. 15 Feb 2009
• The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice. 11 Feb 2009
• Effect of Piper betle on plasma antioxidant status and lipid profile against D-galactosamine-induced hepatitis in rats. 30 Dec 2008
• Effects of various dietary arginine and lysine concentrations on plasma and liver cholesterol concentrations in rats. 9 Dec 2008
• Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice. 4 Dec 2008
• [The effect of smoking on mean platelet volume and lipid profile in young male subjects] 29 Nov 2008
• Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women. 27 Nov 2008
• Amino acid supplementation decreases plasma and liver triacylglycerols in elderly. 26 Nov 2008
• Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography. 6 Nov 2008
• Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome. 4 Nov 2008
• Hepatitis B virus infection and the risk of coronary atherosclerosis. 30 Oct 2008
• Remnant lipoprotein cholesterol homogenous assay (RemL-C) is closely associated with very-low-density lipoprotein remnants: comparison with the immunoseparation assay. 30 Oct 2008

See a longer list of these articles.

Technical information about 'Cholesterol, VLDL'

Definition: Cholesterol which is contained in or bound to very low density lipoproteins (VLDL). High circulating levels of VLDL cholesterol are found in HYPERLIPOPROTEINEMIA TYPE IIB. The cholesterol on the VLDL is eventually delivered by LOW-DENSITY LIPOPROTEINS to the tissues after the catabolism of VLDL to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LDL.

Registry Number: 0

Descriptor UI: D015243

Alternative terms: Cholesterol, VLDL; Prebetalipoprotein Cholesterol; Cholesterol, Prebetalipoprotein; VLDL Cholesterol; Pre-beta-Lipoprotein Cholesterol; Cholesterol, Pre-beta-Lipoprotein; Pre beta Lipoprotein Cholesterol; Very Low Density Lipoprotein Cholesterol;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D10.532.599.700; D10.570.938.208.285; D12.776.521.622.700;

History Note: 2007 (1989)